These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25355145)

  • 1. [Updates on Lifestyle-Related Diseases and Bone Metabolism. Increase in bone fragility from the viewpoint of bone structural properties].
    Ito M; Chiba K
    Clin Calcium; 2014 Nov; 24(11):1615-20. PubMed ID: 25355145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Updates on Lifestyle-Related Diseases and Bone Metabolism. Mechanism of bone fragility in lifestyle-related disease at material level].
    Saito M
    Clin Calcium; 2014 Nov; 24(11):1621-30. PubMed ID: 25355146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone structural properties and bone strength in CKD].
    Yano S; Sugimoto T
    Clin Calcium; 2013 Jul; 23(7):1007-12. PubMed ID: 23811589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease.
    Bacchetta J; Boutroy S; Vilayphiou N; Juillard L; Guebre-Egziabher F; Rognant N; Sornay-Rendu E; Szulc P; Laville M; Delmas PD; Fouque D; Chapurlat R
    J Bone Miner Res; 2010 Apr; 25(4):849-57. PubMed ID: 19775204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone architecture and strength in diabetes mellitus].
    Okazaki R
    Clin Calcium; 2013 Jul; 23(7):1001-6. PubMed ID: 23811588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The assessment of bone quality in lifestyle-related diseases].
    Yamauchi M
    Clin Calcium; 2016 Jan; 26(1):65-72. PubMed ID: 26728532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structural approach to skeletal fragility in chronic kidney disease.
    Leonard MB
    Semin Nephrol; 2009 Mar; 29(2):133-43. PubMed ID: 19371804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Updates on Lifestyle-Related Diseases and Bone Metabolism. CKD-related osteoporosis].
    Yamada S; Inaba M
    Clin Calcium; 2014 Nov; 24(11):1605-13. PubMed ID: 25355144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.
    Iwasaki Y; Kazama JJ; Fukagawa M
    Biomed Res Int; 2017; 2017():3485785. PubMed ID: 28421193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of menopause and metabolic disease on trabecular and cortical bone assessed by peripheral quantitative computed tomography (pQCT).
    Tsurusaki K; Ito M; Hayashi K
    Br J Radiol; 2000 Jan; 73(865):14-22. PubMed ID: 10721315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between endogenous parathyroid hormone and bone metabolism/geometry in female patients treated with glucocorticoid.
    Kaji H; Yamauchi M; Chihara K; Sugimoto T
    Horm Metab Res; 2008 Jan; 40(1):60-5. PubMed ID: 18072075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of bone architecture and strength in men and women with stage 5 chronic kidney disease.
    West SL; Jamal SA
    Semin Dial; 2012 Jul; 25(4):397-402. PubMed ID: 22686655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
    Fox J; Miller MA; Recker RR; Turner CH; Smith SY
    Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe cortical and trabecular osteopenia in secondary hyperparathyroidism.
    Brancaccio D; Di Leo C; Bestetti A; Carpani P; Tagliabue L; Cozzolino M; Galassi A; Luigi Tarolo G; Gallieni M
    Hemodial Int; 2003 Apr; 7(2):122-9. PubMed ID: 19379351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes.
    Sellmeyer DE; Civitelli R; Hofbauer LC; Khosla S; Lecka-Czernik B; Schwartz AV
    Diabetes; 2016 Jul; 65(7):1757-66. PubMed ID: 27329951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is it possible to-predict fracture in CKD patients?].
    Tsukamoto Y
    Clin Calcium; 2016 Sep; 26(9):1295-300. PubMed ID: 27561344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CKD Stages, Bone Metabolism Markers, and Cortical Porosity Index: Associations and Mediation Effects Analysis.
    Xiong Y; He T; Wang Y; Liu WV; Hu S; Zhang Y; Wen D; Hou B; Li Y; Zhang P; Liu J; He F; Li X
    Front Endocrinol (Lausanne); 2021; 12():775066. PubMed ID: 34803931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Updates on Lifestyle-Related Diseases and Bone Metabolism. The metabolic syndrome and bone metabolism].
    Yamaguchi T
    Clin Calcium; 2014 Nov; 24(11):1599-604. PubMed ID: 25355143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.